Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Electrical stimulation and stem cell subdural implantation decrease microglia reactivity after spinal cord injury

  • Mannino, Loris
  • Marracino, Paolo
  • López-Mocholi, Eric
  • Pedraza-Boti, Maria
  • Bernardi, Dario
  • Balucani, Marco
  • Andre, Franck M.
  • Mir, Lluis M.
  • Ivashchenko, Sergiy
  • López-Grobas, Iago
  • Buceta-Fernández, Javier
  • Gisbert-Roca, Fernando|||0000-0003-3937-5822
  • Navarro-Páez, Francisco|||0000-0002-4383-3681
  • Martínez-Ramos, Cristina|||0000-0002-6540-4714
  • Monleón Pradas, Manuel|||0000-0001-6457-0414
[EN] Background: Contusive spinal cord injury (SCI) leads to severe and permanent motor, sensory, and autonomic deficits, resulting from both the initial mechanical damage and subsequent secondary pathological cascades. Besides, electrical stimulation (ES) and stem cell therapies have emerged as promising strategies to promote axonal regeneration and neuronal plasticity. Methods: We designed a new implantable device, an Electro Pulsed Biohybrid (EPB) device, to provide local ES and carry stem cells (hMSC and iNSC) for subdural implantation, wired and wireless controlled. We assessed locomotion and sensory outputs, cell migration, neuroinflammation, gliosis, fibrosis, and neuronal survival. Results: The consecutive application of microsecond pulsed electric fields (mu sPEFs) into two different configurations during ten days and further continuous current during five days significantly enhanced the migration and engraftment of the implanted hMSC and a significant reduction in the number of microglia injury-dependent reactive cells. The ES did not exacerbate gliosis, fibrosis, neuropathic pain, or neuronal loss after primary trauma, instead, the electrically stimulated animals in comparison with the non-stimulated controls were able to perform better reducing the time during running. Consistent results were obtained with a wireless and wired configuration for the ES supply. Conclusions: The applied sequence of mu sPEFs and direct current local stimulation contributed to the early immunomodulation, reducing the acute immunoreactivity involved in further secondary damage, and enhanced implanted hMSC migration, providing a versatile platform for cell therapy and ES combinatorial approach in the SCI treatment., The publication of the present research is funded and fundamental part of the project RISEUP EU grant (ref. 964562) from the FetOpen H2020 program, the project PID2021-1243590B-I00, PID2024-159513OB-I00 (to V.M-M), PID2022-137436NB-I00 (to J.B.) by MICIN/AEI/10.13039/501100011033/FEDER, and by the Generalitat Valenciana (GVA) PROMETEO grant CIPROM/2022/25 (V.M-M, L.M, and J.B.) . The GVA also funded part of the equipment employed in this work and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020) and the European Union; Fondo Europeo de Desarrollo Regional (FEDER) included in the Programa Operativo FEDER de la Comunidad Valenciana 2014-2020. I.G. acknowledges funding from the Margarita Salas Fellowship (Ref. MS21-128) and the HORIZON-MSCA-2022-PF-01-01 program (grant no. 101107228).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Transplantation of Human Fetal Spinal cord-derived NPCs Primed with a Polyglutamate-conjugated Rho/Rock Inhibitor as a Therapy for Acute Spinal Cord Injury

  • Giraldo, Esther|||0000-0001-5488-3011
  • Bonilla, Pablo
  • Mellado, Mara
  • García-Manau, Pablo
  • Rodó, Carlota
  • Alastrue, Ana
  • López, Eric
  • Carreras Moratonas, Elena
  • Pellisé, Ferran
  • Dordevic, Snezana
  • Vicent, María J.
  • Moreno Manzano, Victoria
[EN] Neural precursor cell (NPC) transplantation represents a promising therapy for treating spinal cord injuries (SCIs); however, despite successful results obtained in preclinical models, the clinical translation of this approach remains challenging due, in part, to the lack of consensus on an optimal cell source for human neuronal cells. Depending on the cell source, additional limitations to NPC-based therapies include high tumorigenic potential, alongside poor graft survival and engraftment into host spinal tissue. We previously demonstrated that NPCs derived from rat fetal spinal cords primed with a polyglutamate (PGA)-conjugated form of the Rho/Rock inhibitor fasudil (PGA-SS-FAS) displayed enhanced neuronal differentiation and graft survival when compared to non-primed NPCs. We now conducted a similar study of human-fetal-spinal-cord-derived NPCs (hfNPCs) from legal gestational interruptions at the late gestational stage, at 19-21.6 weeks. In vitro, expanded hfNPCs retained neural features, multipotency, and self-renewal, which supported the development of a cell banking strategy. Before transplantation, we established a simple procedure to prime hfNPCs by overnight incubation with PGA-SS-FAS (at 50 ¿M FAS equiv.), which improved neuronal differentiation and overcame neurite-like retraction after lysophosphatidic-acid-induced Rho/Rock activation. The transplantation of primed hfNPCs into immune-deficient mice (NU(NCr)-Foxn1nu) immediately after the eighth thoracic segment compression prompted enhanced migration of grafted cells from the dorsal to the ventral spinal cord, increased preservation of GABAergic inhibitory Lbx1-expressing and glutamatergic excitatory Tlx3-expressing somatosensory interneurons, and elevated the numbers of preserved, c-Fos-expressing, activated neurons surrounding the injury epicenter, all in a low percentage. Overall, the priming procedure using PGA-SS-FAS could represent an alternative methodology to improve the capabilities of the hfNPC lines for a translational approach for acute SCI treatment., This research was funded by Fundacio Marato TV3 2017/refs.20172230, 20172231, Agencia Valenciana de Innovacion (AVI) (INNVAL10/19/047 and Grants RTI2018-095872-B-C21 and PDI20211243590B-I00/ERDF funded by MCIN/AEI//10.13039/501100011033 and by ERDF A way of making Europe). This project was also funded by Project 964562 (RISEUP), H2020 FetOpen program.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Rehabilitation enhances epothilone-induced locomotor recovery after spinal cord injury

  • Griffin, Jarred M.
  • Hingorani Jai Prakash, Sonia
  • Bockemühl, Till
  • Benner, Jessica M
  • Schaffran, Barbara
  • Moreno-Manzano, Victoria
  • Büschges, Ansgar
  • Bradke, Frank
[EN] Microtubule stabilization through epothilones is a promising preclinical therapy for functional recovery following spinal cord injury that stimulates axon regeneration, reduces growth-inhibitory molecule deposition and promotes functional improvements. Rehabilitation therapy is the only clinically validated approach to promote functional improvements following spinal cord injury. However, whether microtubule stabilization can augment the beneficial effects of rehabilitation therapy or act in concert with it to further promote repair remains unknown. Here, we investigated the pharmacokinetic, histological and functional efficacies of epothilone D, epothilone B and ixabepilone alone or in combination with rehabilitation following a moderate contusive spinal cord injury. Pharmacokinetic analysis revealed that ixabepilone only weakly crossed the blood¿brain barrier and was subsequently excluded from further investigations. In contrast, epothilones B and D rapidly distributed to CNS compartments displaying similar profiles after either subcutaneous or intraperitoneal injections. Following injury and subcutaneous administration of epothilone B or D, rats were subjected to 7 weeks of sequential bipedal and quadrupedal training. For all outcome measures, epothilone B was efficacious compared with epothilone D. Specifically, epothilone B decreased fibrotic scaring which was associated with a retention of fibronectin localized to perivascular cells in sections distal to the lesion. This corresponded to a decreased number of cells present within the intralesional space, resulting in less axons within the lesion. Instead, epothilone B increased serotonergic fibre regeneration and vesicular glutamate transporter 1 expression caudal to the lesion, which was not affected by rehabilitation. Multiparametric behavioural analyses consisting of open-field locomotor scoring, horizontal ladder, catwalk gait analysis and hindlimb kinematics revealed that rehabilitation and epothilone B both improved several aspects of locomotion. Specifically, rehabilitation improved open-field locomotor and ladder scores, as well as improving the gait parameters of limb coupling, limb support, stride length and limb speed; epothilone B improved these same gait parameters but also hindlimb kinematic profiles. Functional improvements by epothilone B and rehabilitation acted complementarily on gait parameters leading to an enhanced recovery in the combination group. As a result, principal component analysis of gait showed the greatest improvement in the epothilone B plus rehabilitation group. Thus, these results support the combination of epothilone B with rehabilitation in a clinical setting., This work was supported by The International Foundation for Research in Paraplegia (IRP), Wings for Life (WfL), The German Research Foundation (DFG), The European Comission funded inititiaves ERANET-Neuron AXON REPAIR and ERANET-Neuron RATER SCI (JTC2016) (F.B.), the grant PDI2021-1243590B-I00/ERDF funded by the Spanish Ministry of Science and Innovation (MICINN), the Spanish State Research Agency (AEI) and the European Regional Development Fund (ERDF). F.B. and A.B. are members of the Nordrhein-Westfalen (NRW) network iBehave. F.B. is a member of the DFGfunded excellence cluster ImmunoSensation2, the DFG Collaborative Research Centers (SFBs) 1089 and 1158, the DFG priority programs (SPP) 2395 and is a recipient of the Roger de Spoelberch Prize. A.B. is a member of SFB1451, the DFG-funded Research Training Group 1960 (RTG1960) and the DFG/National Science Foundation (NSF) funded NeuroNex project Communication, Coordination, and Control in Neuromechanical Systems.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Fetal rat neural progenitor cell transplantation after spinal cord injury improves motor recovery following optogenetic stimulation

  • Sanchez-Martin, Maria del Mar
  • Alastrue-Agudo, Ana
  • López-Mocholí, Eric
  • Martín-Pérez, Samuel
  • Maninno, Lois
  • Fraga Sánchez, Ana Isabel
  • Vidal-Beneyto, Quique
  • Conesa, Ana
  • van Niekerk, Erna
  • Tuszynski, Mark
  • Moreno-Manzano, Victoria
  • Giraldo, Esther|||0000-0001-5488-3011
  • Paniagua G
  • Monreal-Trigo, Javier|||0000-0002-4067-1867
  • Terrés-Haro, José Manuel|||0000-0001-5794-7332
[EN] Spinal cord injury (SCI) disrupts communication between the brain and the spinal circuits, resulting in severe motor, sensory, and autonomic dysfunctions. Transplantation of neural progenitor cells (NPCs) has been demonstrated to provide multiple benefits; however, limited graft survival and neuronal differentiation must be overcome to achieve improved results. Here, we explore the optogenetic modulation of rat spinal cord-derived NPC expressing channelrhodopsin-2 (ChR2) through adeno-associated virus serotype 9-mediated transduction, transplanted into the sub-acute stage after SCI. Daily blue-light stimulation and ChR2-dependent activation control of the modified NPC significantly enhanced locomotor skills, run speed, sustained walking coordination, and body stability in a rat SCI model. Engrafted rat NPC-ChR2 reduces astrocytic reactivity and the injured area volume, preserves a higher number of descending propriospinal neurons above the injury and a higher innervation of 5-hydroxytryptamine fibers to choline acetyltransferase-positive motoneurons below the injury, and the increased vesicular glutamate transporter expression suggests an enhanced excitatory synaptic activity. Overall, sustained activation of rat NPC post-transplantation offers a promising strategy for improved locomotor recovery following SCI., The publication of the present research is funded and part of the projects PID2021-1243590B-I100 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU and RTI2018-095872-B-C21 (to V.M.M) by MICIN/AEI/10.13039/501100011033/FEDER, EU, "Una manera de hacer Europa," and by the Generalitat Valenciana (GVA) PROMETEO grant CIPROM/2022/25 (to V.M.M) . The GVA also funded part of the equipment employed in this work and co-financed with ERDF funds (OP ERDF of Comunitat Valenciana 2014-2020) and the UE; Fondo Europeo de Desarrollo Regional (FEDER) included in the Programa Operativo FEDER de la Comunidad Valenciana 2014-2020. The authors also thank Dr. Beatriz Martinez Rojas, Dr. Sonia Jai Hingorani, and Dr. Maria Pedraza for their scientific discussion and suggestions; Marta Llansona for her technical support in chromatographic measurements; and Stuart P. Atkinson for English editing.